Topical application of recombinant activated factor VII during cesarean section for placenta previa
OPEN American journal of obstetrics and gynecology | 22 Feb 2017
BT Schjoldager, E Mikkelsen, MR Lykke, J Præst, AM Hvas, L Heslet, NJ Secher, JD Salvig and N Uldbjerg
Abstract
During cesarean delivery in patients with placenta previa, hemorrhaging after removal of the placenta is often challenging. In this condition, the extraordinarily high concentration of tissue factor at the placenta site may constitute a principal of treatment as it activates coagulation very effectively. The presumption, however, is that tissue factor is bound to activated factor VII (FVIIa).
- Tweets*
- 19
- Facebook likes*
- 1
- Reddit*
- 0
- News coverage*
- 0
- Blogs*
- 0
- SC clicks
- 1
- Concepts
- Placental abruption, Obstetrics, Factor VII, Caesarean section, Placenta praevia, Placenta accreta, Childbirth
- MeSH headings
- -
comments powered by Disqus
* Data courtesy of Altmetric.com